175 studies found for:    "Genital Diseases, Female" | Canada
Show Display Options
Rank Status Study
1 Completed ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: ISIS 5132
2 Completed Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel;   Drug: topotecan hydrochloride
3 Recruiting Comparing Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel;   Procedure: quality-of-life assessment
4 Completed Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Conditions: Atrophic Vaginitis;   Atrophy;   Vaginitis
Interventions: Drug: PVC (daily for 21 days, 7 days off);   Drug: PVC (twice weekly)
5 Completed
Has Results
Somatropin Treatment to Final Height in Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Somatropin;   Drug: Ethinyl estradiol;   Drug: Medroxyprogesterone acetate
6 Active, not recruiting Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
7 Completed
Has Results
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel IUS (Mirena, BAY86-5028);   Drug: Medroxyprogesterone acetate
8 Completed Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED
Conditions: Erectile Dysfunction;   Sexual Dysfunction, Physiological
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
9 Active, not recruiting Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
Conditions: Childhood Embryonal Tumor;   Childhood Extracranial Germ Cell Tumor;   Childhood Extragonadal Germ Cell Tumor;   Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Childhood Teratoma;   Ovarian Embryonal Carcinoma;   Ovarian Yolk Sac Tumor;   Stage II Malignant Testicular Germ Cell Tumor;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIC Ovarian Germ Cell Tumor;   Stage III Malignant Testicular Germ Cell Tumor;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIC Ovarian Germ Cell Tumor;   Testicular Choriocarcinoma and Yolk Sac Tumor;   Testicular Embryonal Carcinoma
Interventions: Procedure: conventional surgery;   Drug: cisplatin;   Drug: etoposide;   Biological: bleomycin sulfate;   Other: laboratory biomarker analysis
10 Completed Pain Associated With Endometriosis
Condition: Endometriosis
Interventions: Drug: Danazol Once Weekly;   Drug: Danazol Twice Weekly;   Drug: Placebo Once Weekly;   Drug: Placebo Twice  Weekly
11 Completed Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: cisplatin;   Drug: tirapazamine
12 Completed Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
Condition: Ovarian Cancer
Intervention: Drug: dalteparin
13 Completed
Has Results
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Interventions: Drug: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027);   Drug: Placebo
14 Completed
Has Results
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
Condition: Genital Herpes
Interventions: Drug: Famciclovir;   Drug: Valacyclovir;   Drug: Placebo matching famciclovir;   Drug: Placebo matching valacyclovir
15 Active, not recruiting Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage IVA Uterine Corpus Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Corpus Cancer;   Stage IVB Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: Sunitinib Malate
16 Completed
Has Results
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Conditions: Fallopian Tube Cancer;   Female Reproductive Cancer;   Ovarian Carcinosarcoma;   Ovarian Sarcoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Uterine Sarcoma;   Stage III Ovarian Epithelial Cancer;   Stage III Uterine Sarcoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma;   Uterine Leiomyosarcoma
Intervention: Drug: ziv-aflibercept
17 Active, not recruiting OSCA - Olaparib Standard of CAre Study
Condition: Platinum-sensitive Recurrent Serous Ovarian Cancer
Intervention: Other: Data Collection
18 Active, not recruiting TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: AMG 386 Placebo;   Drug: Paclitaxel
19 Recruiting A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Oral rucaparib
20 Recruiting A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Rucaparib;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years